research use only
Cat.No.S2368
|
In vitro |
0.5MNAOH : 4.32 mg/mL
DMSO
: Insoluble
Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 180.16 | Formula | C7H8N4O2 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 83-67-0 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | 3,7-Dimethylxanthine | Smiles | CN1C=NC2=C1C(=O)NC(=O)N2C | ||
| In vitro |
Theobromine (3,7-Dimethylxanthine) is a xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than theophylline and is also a less powerful stimulant of smooth muscle. Unlike caffeine, this compound has practically no stimulant effect on the central nervous system. In contrast, it may improve mood and cognition via peripheral physiological changes. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. |
|---|---|
| In vivo |
LD50: Rabbits >200mg/kg (i.g.) |
References |
|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT01659060 | Completed | Hypertension Pregnancy-induced |
Laval University |
July 2008 | Phase 2 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.